You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,253,185


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,253,185
Title:Amino ceramide-like compounds and therapeutic methods of use
Abstract: The present invention provides amino ceramide-like compounds which inhibit glucosyl ceramide (GlyCer) formation by inhibiting the enzyme GlyCer synthase, thereby lowering the level of glycosphingolipids. The compounds of the present invention have improved GlcCer synthase inhibition activity and are therefore useful in therapeutic methods for treating various conditions and diseases associated with altered glycosphingolipid levels.
Inventor(s): Shayman; James A. (Ann Arbor, MI), Harris; David J. (Lexington, MA), Siegel; Craig (Woburn, MA), Nelson; Carol A. (Westford, MA), Copeland; Diane P. (North Billerica, MA)
Assignee: The Regents of the University of Michigan (Ann Arbor, MI) Genzyme Corporation (Cambridge, MA)
Application Number:11/119,541
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,253,185
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,253,185: Amino Ceramide-Like Compounds and Therapeutic Methods of Use

Introduction

United States Patent 7,253,185, titled "Amino Ceramide-Like Compounds and Therapeutic Methods of Use," is a significant patent in the field of biomedical research, particularly in the area of ceramide-related therapies. This patent, issued to researchers, outlines novel compounds and methods for inhibiting glucosyl ceramide (GlyCer) formation, which has implications for various therapeutic applications.

Background

Ceramides are a family of lipid molecules that play crucial roles in cellular processes, including cell signaling, apoptosis, and membrane structure. The invention described in this patent focuses on amino ceramide-like compounds that inhibit the enzyme glucosyl ceramide synthase, thereby preventing the formation of glucosyl ceramides. This is important because glucosyl ceramides are involved in various pathological conditions, such as cancer and neurodegenerative diseases.

Patent Claims

Overview of Claims

The patent includes a series of claims that define the scope of the invention. These claims can be categorized into several types:

Composition of Matter Claims

These claims define the chemical structure of the amino ceramide-like compounds. For example, Claim 1 describes a compound of a specific formula, emphasizing the presence of certain functional groups that are critical for its biological activity[4].

Method of Use Claims

These claims outline the therapeutic methods involving the use of these compounds. For instance, Claim 5 describes a method for treating a disease characterized by the abnormal formation of glucosyl ceramides, such as cancer, by administering an effective amount of the amino ceramide-like compound[4].

Use Claims

These claims specify the diseases or conditions that can be treated using the compounds. Claim 10, for example, mentions the use of the compounds for inhibiting the growth of cancer cells[4].

Claim Scope and Coverage

The scope of the claims is critical in determining the patent's coverage and potential infringement. Here are some key aspects:

Chemical Structure

The claims are specific about the chemical structure of the compounds, including the stereochemistry and the presence of particular functional groups. This specificity helps in distinguishing the patented compounds from other similar molecules[4].

Therapeutic Applications

The method of use claims covers a range of therapeutic applications, including cancer treatment and the inhibition of glucosyl ceramide formation. This broadens the patent's scope to include various potential uses in biomedical research and clinical practice[4].

Patent Landscape

Related Patents and Prior Art

To understand the position of this patent within the broader patent landscape, it is essential to consider related patents and prior art. The prior art keywords listed in the patent, such as "ceramide," "cells," and "threo," indicate that the invention builds upon existing research in ceramide biology and chemistry[4].

Competing Patents

Other patents in the field of ceramide research may overlap or complement the claims of this patent. For instance, patents related to ceramide synthase inhibitors or other ceramide-related therapies could be relevant. Conducting a thorough patent search using databases like the USPTO's PatentsView or Google Patents can help identify these competing patents[2][4].

Analyzing Claims Using Patent Analytics

Claim Coverage Matrix

Using tools like ClaimScape® software, one can create a Claim Coverage Matrix to visualize which patents and claims are actively protecting the intellectual property related to amino ceramide-like compounds. This matrix helps in identifying gaps or opportunities in the patent coverage and can be particularly useful for engineers, scientists, and management to determine the value and applicability of the patent claims[3].

Scope Concepts

Categorizing patents by scope concepts, such as the inhibition of glucosyl ceramide formation or the treatment of specific diseases, can provide a powerful tool for filtering and analyzing large numbers of patent claims. This approach helps in understanding the broader landscape and identifying future design opportunities or potential gaps in coverage[3].

Legal and Practical Considerations

Patent Expiration and Status

The patent has expired, which means that the inventions described are now in the public domain. This status is important for companies or researchers looking to use or build upon the inventions without infringing on existing patent rights[4].

Potential for Litigation

Although the patent has expired, understanding its claims and scope can still be crucial for avoiding potential litigation related to similar patents that may still be in force. Companies should conduct thorough patent searches and analyses to ensure they are not infringing on active patents in the same field[5].

Key Takeaways

  • Specific Claims: The patent includes specific claims about the chemical structure and therapeutic use of amino ceramide-like compounds.
  • Therapeutic Applications: The patent covers various therapeutic applications, including cancer treatment and the inhibition of glucosyl ceramide formation.
  • Patent Landscape: The patent is part of a broader landscape of ceramide-related research and therapies.
  • Expired Status: The patent has expired, making its inventions public domain.
  • Analytical Tools: Using patent analytics tools can help in understanding the scope and coverage of the patent claims.

FAQs

What is the main invention described in United States Patent 7,253,185?

The main invention is amino ceramide-like compounds that inhibit glucosyl ceramide synthase and their therapeutic methods of use.

What are the key claims in this patent?

The key claims include composition of matter claims defining the chemical structure of the compounds, method of use claims outlining therapeutic applications, and use claims specifying diseases or conditions that can be treated.

How does this patent fit into the broader patent landscape?

This patent is part of a larger body of research on ceramides and their therapeutic applications, with potential overlaps or complements with other patents in the field.

What is the current status of this patent?

The patent has expired, meaning its inventions are now in the public domain.

Why is it important to analyze the claims and scope of this patent?

Analyzing the claims and scope helps in understanding the patent's coverage, identifying potential gaps or opportunities, and avoiding infringement on similar active patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,253,185

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.